Robot 365 - Xiankangda Biology

　　Project background

　　At present, China is in an important stage of transformation from a manufacturing power to a manufacturing power. In the production workshops of most small and medium-sized enterprises, the level of production automation in some links has gradually matured, but in the research laboratory, it mainly depends on human resources to solve the problem. With the increasing cost of employment, it has become a trend in the medical industry to replace human resources with robots to solve the duplication of work in medical research.

　　Customer topics

　　Guangdong Xiankangda Biotechnology Co., Ltd. is a national high-tech enterprise, which is formed by a group of innovative scientists with interdisciplinary backgrounds of cell biology, genetics, molecular biology, microbiology and biomedicine. In order to provide better solutions for Chinese people's cancer, osteoarthritis, diabetes and other refractory diseases, and to protect human health, Xiankangda Biology and Robot 365 have reached a strategic partnership, focusing on the research and development of stem cell therapy technology, immune cell therapy technology and gene therapy technology, so as to jointly build the future of stem cells.

　　Project solution

　　With its rich experience and excellent product performance, Robot 365 provides the Xiankangda Group with an overall medical laboratory solution in combination with urgent demands and on-site conditions. The stem cell cultivation intelligent workstation of Robot 365 can realize automatic operations such as inoculation, culture medium replacement, cell collection, washing, trypsin treatment, waste disposal, etc., and is suitable for special cell line operations.